Evgeni Grigorov | Pharmacovigilance | OncologyPharmaOnc Trailblazer Award

Published on by Top Pharmaceutical
After Completing the Registration Process, your Biography will be displayed here.

Register by using your Entry ID: 2636

Register Here

Luca Roncati | Pharmacovigilance | Best Academic Researcher Award

Published on by Top Pharmaceutical

Prof. Dr. Luca Roncati | Pharmacovigilance | Best Academic Researcher Award

Link Campus University | Italy

Prof. Dr. Luca Roncati is a distinguished Italian pathologist, physician-scientist, and academic leader whose extensive contributions have significantly advanced modern medical science. With a strong focus on senology, gynecologic oncology, gynecopathology, and hematopathology, he stands as a prominent figure in the global medical community. Dr. Roncati has an impressive record of 228 scientific publications, collectively cited in over 1,073 documents with more than 1,738 total citations, reflecting the profound influence and credibility of his research across various medical disciplines.Renowned for his groundbreaking discoveries, Dr. Roncati is the eponym of the Roncati–Manenti Triad, a key diagnostic concept in gynecologic oncology, and the describer of T rex lymphoma, a rare hematological condition that broadened the understanding of lymphoid malignancies. As a pioneering researcher in COVID-19, his investigations provided critical insights into viral pathogenesis and immune mechanisms, shaping the scientific response during the global pandemic. Furthermore, his innovative work in nanopathology has paved the way for the integration of nanotechnology into modern diagnostic pathology, offering revolutionary approaches to disease detection at the molecular level.Beyond research, Dr. Roncati is a full-time Professor of Pathology at Link Campus University in Rome, where he mentors future medical professionals and drives forward-thinking educational programs in biomedical sciences. Simultaneously, he leads as the Head of the Women’s Health Department at the European Institute of Dermatology in Milan, where his expertise in women’s health, oncology, and diagnostic pathology enhances patient care and clinical outcomes.An award-winning author, academic editor, and inventor of anti-cancer patents, Dr. Roncati’s contributions exemplify the synergy between innovation, clinical excellence, and scientific discovery. His scholarly achievements, coupled with his dedication to advancing medical knowledge, have established him as one of the most influential figures in contemporary pathology and translational medicine. Through his research, publications, and leadership, Prof. Dr. Luca Roncati continues to inspire a new generation of scientists and clinicians in their pursuit of excellence and innovation in healthcare.

Profile: Scopus

Featured Publications

Roncati, L., et al. (2025). Erratum: Long COVID clinical evaluation, research and impact on society: a global expert consensus. Annals of Clinical Microbiology and Antimicrobials.

Roncati, L., et al. (2025). Long COVID clinical evaluation, research and impact on society: a global expert consensus. Annals of Clinical Microbiology and Antimicrobials.

Roncati, L., et al. (2025). pDNA impurities in mRNA vaccines. Editorial, Open Access.

Roncati, L., et al. (2025). Thoracic aortic pseudoaneurysm: Inside its pathophysiology. Vascular.

Roncati, L., et al. (2025). Adjuvant metronomic chemotherapy after surgery in pT1–T2 N0 M0 HER2-positive and ER/PR-positive breast cancer plus targeted therapy, anti-hormonal therapy, and radiotherapy, with or without immunotherapy: A new operational proposal. Editorial, Open Access.

Roncati, L., et al. (2025). Ozone–oxygen therapy to prevent HPV-related cancers of the lower gynecological tract in infected patients: The rationale for further developments. Cancers. [Open Access]

Roncati, L., et al. (2025). COVID-19 and upper limb compression neuropathies: A review. Review Article, Open Access.

Kamini Raghuram | Drug Safety and Risk Management | Best Researcher Award

Published on by Top Pharmaceutical

Dr. Kamini Raghuram | Drug Safety and Risk Management | Best Researcher Award

Staff Neonatologist and Developmental Pediatrician at University of Toronto | Canada

Dr. Kamini Raghuram is a clinician-scientist specializing in developmental and behavioral pediatrics, neonatal-perinatal medicine, and clinical epidemiology. With a strong foundation in pediatrics, she has combined clinical expertise with cutting-edge research to advance outcomes in high-risk and preterm infants. Her work bridges clinical practice, epidemiology, and innovative technological tools such as automated video-based analysis for motor impairment. Dr. Raghuram has been a principal and co-investigator on numerous funded projects and has published extensively in leading pediatric and neonatal journals. She is widely recognized for her dedication to improving long-term neurodevelopmental outcomes in vulnerable infant populations.

Publication Profile 

Orcid

Education 

Dr. Kamini Raghuram completed her Doctor of Medicine (MD) at the University of Toronto, followed by FRCPC training in General Pediatrics, Neonatal and Perinatal Medicine, and Developmental and Behavioral Pediatrics at the same institution. She earned a Master of Science in Clinical Epidemiology and Health Care Research from the Institute of Health Policy, Management, and Evaluation, University of Toronto, where her thesis focused on video-based motor impairment analysis in preterm infants. Earlier, she obtained a Bachelor of Applied Science in Chemical and Biological Engineering from the University of British Columbia, graduating as class valedictorian and recognized for outstanding research proficiency.

Experience 

Dr. Kamini Raghuram has held extensive clinical and academic positions across pediatrics, neonatology, and developmental medicine. She has served as a clinician-investigator, integrating patient care with translational research to develop evidence-based approaches for preterm infants. Her work includes leading clinical trials, advancing quality improvement initiatives, and applying machine learning and automated video analysis for early detection of motor and neurodevelopmental impairments. With expertise spanning neonatal intensive care, developmental follow-up, and health outcomes research, she has collaborated nationally and internationally to improve clinical pathways for high-risk infants. Her experience reflects a unique combination of bedside practice and pioneering research in pediatrics.

Awards and Honors 

Dr. Kamini Raghuram has received numerous awards and funding recognitions for her research and clinical excellence. These include CIHR grants exceeding $2 million, innovation fund competitions, and recognition for her work on neonatal outcomes. She has won presentation and research awards at the University of Toronto, The Hospital for Sick Children, and international conferences. Honors such as the Excellence in Academic Coaching Award, Quality Improvement Award, Canada Graduate Scholarship, and early-career fellowships highlight her leadership and academic impact. Earlier, as an engineering student, she received the Lefevre Gold Medal and delivered the valedictorian address at the University of British Columbia.

Research Focus 

Dr. Kamini Raghuram research focuses on improving neurodevelopmental and health outcomes in preterm and high-risk infants through early detection, intervention, and long-term follow-up strategies. She applies advanced tools, including automated video analysis, MRI biomarkers, and large-scale database studies, to identify predictors of motor and cognitive impairment. Her work integrates clinical epidemiology with neonatal and developmental pediatrics, emphasizing translational approaches from bench to bedside. She is also involved in clinical trials addressing interventions such as coadministration therapies and surgical decision-making in fetal medicine. Her ultimate goal is to enhance early diagnosis, optimize interventions, and improve quality of life for vulnerable children.

Publication Top Notes

Caregiver Experiences, Healthcare Provider Perspectives and Child Outcomes with Virtual Care in a Neonatal Neurodevelopmental Follow-Up Clinic: A Mixed-Methods Study

Automated Movement Analysis to Predict Cerebral Palsy in Very Preterm Infants: An Ambispective Cohort Study

Conclusion

Dr. Kamini Raghuram is a highly deserving candidate for the Best Researcher Award. Her career reflects a rare combination of clinical excellence, research innovation, and dedication to improving outcomes for preterm infants. With substantial grant funding, groundbreaking studies in automated movement analysis, and leadership in advancing neonatal care, she exemplifies the qualities of a leading researcher. While opportunities exist to expand her global influence and further scale her innovations, her proven track record of impactful, patient-centered research makes her an outstanding nominee for this prestigious recognition.

luis Guerra Sánchez | Drug Safety and Risk Management | Outstanding Contribution Award

Published on by Top Pharmaceutical

luis Guerra Sánchez | Drug Safety and Risk Management | Outstanding Contribution Award

Dr. luis Guerra Sánchez, HGU Gregorio Marañon, Spain

Dr. Luis Guerra Sánchez is an esteemed Spanish nurse and researcher with a Ph.D. in Nursing Care Research 🎓 from Universidad Complutense de Madrid. With degrees in Nursing (Graduate & Diploma) 🏥 and a Master’s in Nursing Research, his academic journey reflects excellence and dedication. He has completed over 40 advanced professional trainings 🧠, specializing in chronic care, diabetes, neonatal intensive care, statistics, leadership, and biomedical research 📊🧪. Dr. Sánchez is deeply committed to healthcare innovation, evidence-based practice, and continuous learning, making significant contributions to nursing education and clinical practice. A true advocate for patient-centered care and professional growth.

Publication Profile 

Orcid

Education

Dr. Luis Guerra Sánchez holds a robust academic foundation in nursing, highlighted by a Ph.D. in Investigación en Cuidados de Enfermería 🎓 and a Master’s degree in Investigación en Cuidados from Universidad Complutense de Madrid 🏛️. His commitment to lifelong learning is evident in his completion of over 40 specialized training programs, covering diverse areas such as chronic patient care, diabetes management, neonatal intensive care, biomedical research, statistics, and healthcare leadership 📊🧪💉. With extensive experience in clinical and academic settings, Dr. Sánchez continues to contribute meaningfully to healthcare excellence and nursing advancement across Spain and beyond.

Awards

Dr. Luis Guerra Sánchez has pursued extensive professional development through a wide array of training programs and certifications 🎓. His credentials include courses in research methodology 🧪, statistical analysis 📊, and healthcare management 🏥. He holds specialized certifications in critical care 🚑, cardiology ❤️, and neonatology 👶, reflecting his deep commitment to high-level clinical expertise. With over four decades of continuous learning, his qualifications span from advanced clinical practices to leadership and teaching in healthcare. These achievements underline his dedication to excellence and innovation in patient care, nursing education, and evidence-based medical practice.

Experience

Dr. Luis Guerra Sánchez brings a wealth of experience in both clinical practice and scientific research 🏥📚. His professional journey spans diverse healthcare settings, where he has contributed significantly through patient care, management, and academic mentoring 👨‍⚕️👨‍🏫. With numerous certifications and continuous training in specialized areas such as cardiology, neonatology, and chronic disease management ❤️👶, he exemplifies lifelong learning. His involvement in research projects and data-driven healthcare innovations reflects a strong dedication to evidence-based practice and improving patient outcomes 🔎📈. Dr. Sánchez’s impact extends across clinical, educational, and investigative domains, making him a leader in modern nursing.

Research Focus

Dr. Luis Guerra Sánchez’s scholarship sits at the crossroads of clinical nutrition, cardiovascular nursing, and patient‑safety science. His randomized trials explore how tailored dietary strategies can reverse malnutrition, boost functional capacity, and elevate quality of life in chronic heart‑failure patients 🫀📈. Parallel work standardises intravenous therapies and analgesia–sedation practices in ICUs, tightening medication‑safety protocols 💉🔒. Through multicentre audits, he spotlights delirium, restraint use, and nutritional risk—generating evidence for nurse‑led interventions that cut complications and hospital days 🏥⏱️. Overall, Luis champions evidence‑based, nurse‑driven care models that fuse nutrition science with cardiology and critical‑care best practices, improving outcomes across vulnerable populations .

Publication Top Notes

  • Effect of a double nutritional intervention on the nutritional status, functional capacity, and quality of life of patients with chronic heart failure: 12-month results from a randomized clinical trial
  • Standardization and Chemical Characterization of Intravenous Therapy in Adult Patients: A Step Further in Medication Safety.
  • Assessment of analgesia, sedation, physical restraint and delirium in patients admitted to Spanish intensive care units. Proyecto ASCyD
  • Nutritional intervention in patients with heart failure. 3 month results of a clinical trial
  • [Prevalence of undernutrition in hospital patients with unbalanced heart failure; subjective global assessment like prognosis sign].

  • [Nutritional screening in heart failure patients: 5 methods review].

Josep Allué Creus | Regulatory Affairs | Best Researcher Award

Published on by Top Pharmaceutical

Josep Allué Creus | Regulatory Affairs | Best Researcher Award

Prof. Dr. Josep Allué Creus, Apdena Consult, Spain

Prof. Dr. Josep Allué Creus 🧪🌿 is a renowned Doctor of Pharmacy and expert in phytotherapy. A retired Professor of Plant Physiology at the Universitat Autònoma de Barcelona 🎓, he co-directs the Master’s and Postgraduate Programs in Phytotherapy at IL3, University of Barcelona 💻📘. He serves as the spokesperson for Medicinal Plants and Homeopathy at the College of Pharmacists of Barcelona 💊 and is a founding member and treasurer of SEFIT. As part of AEEM’s Natural Products group 👩‍⚕️, his research integrates botanical science and women’s health, making him a leader in herbal medicine 🌸🔬.

Publication Profile

Orcid

Education

Prof. Dr. Josep Allué Creus 🎓🧪 exemplifies academic excellence with a prestigious Doctorate in Pharmacy, laying the cornerstone for his remarkable contributions to the fields of phytotherapy and medicinal plant sciences 🌿📚. His doctoral foundation reflects a deep-rooted dedication to advancing healthcare through botanical knowledge and evidence-based research 🔬💊. Prof. Allué’s commitment to scientific integrity and innovation has positioned him as a respected authority in natural medicine 🌱, influencing both academic circles and clinical applications. His passion for teaching and research continues to inspire the next generation of pharmacists and phytotherapy experts across Spain and beyond 🌍👨‍🏫.

Experience

Prof. Dr. Josep Allué Creus 📘🌿 has made significant academic and teaching contributions as a Professor of Plant Physiology at the Universitat Autònoma de Barcelona 🏛️. Throughout his career, he nurtured and mentored countless students, shaping future generations of scientists, pharmacists, and healthcare professionals 👩‍⚕️🧑‍🔬. His passion for education did not end with retirement—he continues to share his expertise as a co-director of master’s and postgraduate programs in phytotherapy through IL3 at the University of Barcelona 🎓🌱. Prof. Allué’s unwavering dedication to lifelong learning and botanical sciences remains a beacon of inspiration in academic circles 🔬📖.

Research Focus

Prof. Dr. Josep Allué Creus 🧠🌿 focuses on two dynamic research domains: phytotherapy and neurodegenerative diseases. His pioneering work on medicinal plant extracts 🌱, such as hemp-derived compounds, highlights their therapeutic potential for conditions like gastrointestinal disorders and dyspepsia 💊. Parallelly, he contributes extensively to cutting-edge Alzheimer’s research, especially in biomarker development for early detection of cognitive decline 🧬🧪. His publications delve into plasma-based assays for amyloid and tau proteins, advancing non-invasive diagnostics in neurology 🧫🔍. Bridging natural medicine and modern neurobiology, Prof. Allué champions holistic innovation in health science.

Publication Top Notes

Hemp Extract (<i>Extractum Cannabis</i>) in the Treatment of Gastrointestinal Distress and Dyspepsia: Historical Insights from Barcelona, Spain

Clinical performance of an antibody-free assay for plasma Aβ42/Aβ40 to detect early alterations of Alzheimer’s disease in individuals with subjective cognitive decline

Clinical utility of an antibody-free LC-MS method to detect brain amyloid deposition in cognitively unimpaired individuals from the screening visit of the A4 Study

Contribution of clinical information to the predictive performance of plasma β-amyloid levels for amyloid positron emission tomography positivity

Detecting amyloid positivity in early Alzheimer’s disease using combinations of plasma Aβ42/Aβ40 and p-tau

Head-to-Head Comparison of 8 Plasma Amyloid-β 42/40 Assays in Alzheimer Disease

Individualized prognosis of cognitive decline and dementia in mild cognitive impairment based on plasma biomarker combinations

Performance of the plasma Aβ42/Aβ40 ratio, measured with a novel HPLC-MS/MS method, as a biomarker of amyloid PET status in a DPUK-KOREAN cohort

The global Alzheimer’s Association round robin study on plasma amyloid β methods

Plasma amyloid, phosphorylated tau, and neurofilament light for individualized risk prediction in mild cognitive impairment

Outstanding Phenotypic Differences in the Profile of Amyloid-β between Tg2576 and APPswe/PS1dE9 Transgenic Mouse Models of Alzheimer’s Disease

Ms. Tahere Abdollahi |Drug Safety and Risk Management |Women Researcher Award

Published on by Top Pharmaceutical

Ms. Tahere Abdollahi|Drug Safety and Risk Management |Women Researcher Award

Ms. Tahere Abdollahi at Hamadan University of Medical Sciences,Iran

PROFILE  

Orcid

Early Academic Pursuits 🎓

Tahere Abdollahi embarked on her academic journey with a strong foundation in Occupational Health Engineering. She pursued a Master’s degree in this field at Hamadan University of Medical Sciences, which is renowned for producing professionals with expertise in healthcare and occupational safety. Her academic focus on occupational health was driven by a passion for improving workplace environments, particularly in industries dealing with hazardous substances. During her early years as a student, Tahere developed a keen interest in the impact of industrial chemicals and drugs on human health, a theme that would shape her future research.

Her commitment to academic excellence allowed her to gain a comprehensive understanding of the science of occupational health. She was actively involved in laboratory work, field studies, and academic discussions, all of which solidified her knowledge base in the subject. These early academic experiences laid the groundwork for her future endeavors as an occupational health consultant and researcher.

Professional Endeavors 👩‍⚕️

Currently, Tahere Abdollahi holds a significant role as an Occupational Health Consultant in the medical equipment industry. Her expertise allows her to offer critical insights into the health risks associated with medical environments and equipment, ensuring that workers in this sector remain protected from occupational hazards. Her consulting work extends to evaluating the safety of equipment used in healthcare settings, as well as suggesting improvements to reduce potential risks.

In addition to her consulting role, Tahere continues to engage in academic and research activities. Her involvement in ongoing research projects reflects her commitment to advancing the field of occupational health. By focusing on industries with high exposure risks, such as ferrosilicon production and oncology nursing, she highlights the often-overlooked dangers in these environments, contributing to the improvement of workplace health standards.

Contributions and Research Focus 🔬

One of Tahere’s notable research contributions includes a study titled “Evaluating oxidative stress biomarkers in oncology nurses exposed to antineoplastic drugs: A cross-sectional study”, which is indexed in Scopus. This research delved into the oxidative stress faced by nurses who are regularly exposed to antineoplastic drugs, which are commonly used in cancer treatments. The study provided valuable data on the biomarkers associated with oxidative stress in these healthcare workers, emphasizing the need for better protective measures and health monitoring in hospitals and oncology departments.

Her current research focuses on the ferrosilicon industry, where she is studying the impact of chemical exposure on workers’ health. The goal of this study is to identify key biomarkers of oxidative stress and other health concerns that can arise from prolonged exposure to industrial chemicals, with a view to proposing solutions that can mitigate these risks. Through these projects, Tahere has made a significant contribution to both the occupational health and healthcare fields by addressing the unseen risks faced by workers.

Accolades and Recognition 🏆

While still early in her career, Tahere Abdollahi has already gained recognition for her research work, particularly her study on oxidative stress in oncology nurses. This research has been published in a Scopus-indexed journal, an achievement that speaks to the quality and relevance of her work. Her contribution to occupational health through her research is commendable, and her work has the potential to influence safety regulations and practices in healthcare settings.

Tahere has also applied for the Best Researcher Award in the international top pharmaceutical awards, which would serve as a well-deserved recognition for her ongoing dedication and impactful work in the field of occupational health.

Impact and Influence 🌍

The research and professional contributions of Tahere Abdollahi extend beyond academia. Her work on evaluating oxidative stress biomarkers among healthcare professionals has highlighted the potential long-term health risks faced by oncology nurses and other healthcare workers. This has led to a broader discussion in medical circles about improving safety protocols and protective measures for workers exposed to hazardous substances in hospitals and medical settings.

Her influence is also being felt in the industrial sector, where her ongoing research on ferrosilicon industries could lead to substantial improvements in workplace safety standards. By focusing on the health risks associated with chemical exposure, she is helping to drive the development of better monitoring systems and protective measures for workers in high-risk industries.

Legacy and Future Contributions 🌟

As an emerging researcher and consultant, Tahere Abdollahi’s future contributions are poised to have a lasting impact on occupational health, particularly in high-risk industries such as healthcare and chemical manufacturing. Her studies on oxidative stress and chemical exposure have the potential to influence policy changes and lead to more stringent safety regulations, benefiting workers across a wide range of sectors.

Her ongoing research promises to add further depth to her already impressive body of work, with a focus on enhancing worker safety and health in environments where exposure to hazardous substances is common. Tahere is likely to continue collaborating with experts across industries, contributing her knowledge and expertise to safeguard the health of countless workers.

In the years to come, her legacy will likely include being a key advocate for worker safety in occupational health. Her work will not only serve as a blueprint for future researchers but will also drive real-world changes in occupational safety standards.

Conclusion ✨

Tahere Abdollahi is a rising star in the field of occupational health engineering. Her academic and professional background, coupled with her impactful research on healthcare workers and industrial safety, positions her as an influential figure in her field. Through her work, she continues to champion the health and safety of workers, and her ongoing contributions are sure to leave a lasting mark on occupational health practices and policies worldwide.

🎓Publication 

Evaluating oxidative stress biomarkers in oncology nurses exposed to antineoplastic drugs: A cross-sectional study

  • Authors   : Abdollahi, T.; Ranjbar, A.; Faradmal, J.; Mohraz, M.H.; Assari, M.J.
  • Journal    :Oncology Nursing
  • Year         :2024